Icon
+91 94997 68112
Login Register

ProAir HFA - (EQ 0.09MG BASE/INH; Aerosol, Metered: Inhalation)

Albuterol Sulphate Teva
EQ 0.09MG BASE/INH; Aerosol, Metered: Inhalation
More Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Yes
******* ** *** ****** *** **** ***-*** ***. ********** ** ******* **** ******* ***** ********* ** *** ***** ** ********** ******* *** * ******* ******** ******* ** ****** * ******* ******* ** ******® *** ******** ** ******** **, **** (** ******* ** ******* *************) *** ** ********* ******** ******* ********* ***** **** **, ****. ******* *** *** ******** ********* ******** ***. ********* ** ****'* *** **** **-*, **** **** *** ********* ******* *********** ** ***** ******* ** ****. ********* ** ****** *******, ** ** **** ********* **** *******. ***** ***** **** ** ****** ** ** ******* ********* (*** **, ****), ********* (*** *, ****) *** ********* (*** **, ****) *** *** ************ **** ** ****. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ***** ** **** ***** *** ***** ** ********* *** *** ***** *** ** ****** ***** ** ****** * ****** ***** *******.
ProAir HFA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10
******* ******* ******* ******* ******* ******* ******* ******* *** ********* (***** ****** *******) *** ********* (***** ****** *******) *** ********* (***** ****** *******)
***** ******* ******* ******* ******* ******* ******* ******* *** ********* (***** ****** *******) *** ********* (***** ****** *******) *** ********* (***** ****** *******)
****** *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** ****** ******** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** ***** *, **** ******* ******** ******** ** *** **, ****
***** ** \ ** **** **, **** ******* ******** ******** ** *** **, ****
****** ** \ ** *** **, **** ******* **** *** ****** *** ****
  1. **** **, **** : ******* ******** **** ***** *** **** ** *** ***-*** *** *********** ******* '***-**** **, **** *** '***-**** *, ****.
  2. **** *, **** : **** ********* ******* ** ******** ** ********.
  3. *** **, **** : ********** *** ********* **** ******* ***** ********* ** *** ***** ** ********** ***** *** * ******* ******** ******* ** ****** * ******* ******* ** ******® *** ******** ** ******** **, **** (** ******* ** ******* *************) *** ** ********* ******** ******* ********* ***** **** **, ****..
  4. *** *, **** : ***** ******** **** ********* **** ** ****** ** ** ******* ********* (*** **, ****), ********* (*** *, ****) *** ********* (*** **, ****).
  5. *** **, **** : **** **** ***** ** ** ** ********.
  6. *** *, **** : **** ******* ***** ** *********.
  7. *** **, **** : ****** ******** **** ********* **** ** ******.
  8. *** *, **** : **** **** ****** **** ************ ** ’***, ’***, ’***, ’***, ’***, *** ’*** ******.
  9. *** **, **** : **** ***** *** ******* ********* ******* ****** **** ******* ************ ** ’***, ’***, ’***, ’***, *** ’*** ******.
  10. *** **, **** : **** ******** ******** **** ***** *** **** ** ******.
  11. *** **, **** : **** **** **** ******** **** ************ ** ****** ** '***, '***, '***, '***, '***, '***, '***, '*** *** '***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.